somes

Discharge Report: Innovative Medicines Initiative 2 (2015)

Summary

The European Parliament approved the 2015 budget discharge for the Innovative Medicines Initiative 2 Joint Undertaking, noting clean audit results despite some implementation delays.
10 29.09.2017
Other
health
budgetary control
administrative law
public administration
research and intellectual property

Key points

  • The European Parliament granted discharge for the 2015 budget implementation of the Innovative Medicines Initiative 2 Joint Undertaking.
  • The Court of Auditors issued a clean opinion, confirming the legality and regularity of the underlying transactions for the year 2015.
  • Budget implementation rates showed a slight decrease compared to 2014, primarily due to delays in Horizon 2020 project negotiations.
  • An audit identified scientific weaknesses in a beneficiary's work, leading to the termination of their participation and the reimbursement of over 398,000 euros.
Documents (PDFs)
REPORT on discharge in respect of the implementation of the budget of the Innovative Medicines Initiative 2 Joint Undertaking for the financial year 2015 Discharge 2015: Innovative Medicines Initiative 2 Joint Undertaking (IMI)
These raw data are provided by the Open Data Portal of the European Union (data.europa.eu) and are licensed under ODC-BY 1.0.